Top Biomed Stock Signal: ACHL
Report Date: 01-28-2024
Symbol: ACHL - Achilles Therapeutics plc
Sector:
Industry:
Top Biomed Stock Signal: ACHL
Achilles Therapeutics plc (ACHL)
245 Hammersmith Road
London, W6 8PW
Phone: 44 20 8154 4600
Website: https://www.achillestx.com
CEO: Dr. Iraj Ali
NASDAQ, Nasdaq Global Select
Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various types of solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. It is also developing products for use in the treatment of head and neck squamous cell carcinoma, renal cell carcinoma, triple negative breast cancer, and bladder cancer. The company was founded in 2016 and is headquartered in London, the United Kingdom.